Orano Med LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2009-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.arevamed.com
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Phase 1
Recruiting
- Conditions
- Cervical CancerColon CancerNSCLCBreast CancerCutaneous MelanomaProstate Cancer Metastatic
- Interventions
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Orano Med LLC
- Target Recruit Count
- 55
- Registration Number
- NCT05283330
- Locations
- 🇺🇸
Northwestern University Robert H Lurie Medical Research, Chicago, Illinois, United States
🇺🇸UK Markey Cancer Center, Lexington, Kentucky, United States
🇺🇸Advanced Molecular Imaging and Therapy, Glen Burnie, Maryland, United States
Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients
- First Posted Date
- 2021-12-10
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Orano Med LLC
- Target Recruit Count
- 69
- Registration Number
- NCT05153772
- Locations
- 🇺🇸
Rocky Mountain Cancer Center, Denver, Colorado, United States
🇺🇸Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸Louisiana State University (LSU) Health Sciences Center - New Orleans, Metairie, Louisiana, United States
Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET
- First Posted Date
- 2018-03-15
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Orano Med LLC
- Target Recruit Count
- 33
- Registration Number
- NCT03466216
- Locations
- 🇺🇸
Excel Diagnostics and Nuclear Oncology Center, Houston, Texas, United States
Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy
Phase 1
Completed
- Conditions
- Peritoneal NeoplasmsPancreatic NeoplasmsBreast NeoplasmsStomach NeoplasmsOvarian Neoplasms
- Interventions
- Other: ²¹²Pb-TCMC-TrastuzumabBiological: trastuzumab
- First Posted Date
- 2011-06-29
- Last Posted Date
- 2016-09-30
- Lead Sponsor
- Orano Med LLC
- Target Recruit Count
- 18
- Registration Number
- NCT01384253
- Locations
- 🇺🇸
University Of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸UCSD Moores Cancer Center, San Diego, California, United States